Technical Analysis for SVRA - Savara, Inc.

Grade Last Price % Change Price Change
grade A 11.31 -1.48% -0.17
SVRA closed down 1.48 percent on Monday, May 20, 2019, on 56 percent of normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SVRA trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Shooting Star Candlestick Bearish -1.48%
Overbought Stochastic Strength -1.48%
Upper Bollinger Band Touch Strength -1.48%
Pocket Pivot Bullish Swing Setup -3.33%
NR7 Range Contraction -3.33%
Stochastic Reached Overbought Strength -3.33%
Gapped Up Strength -3.33%
Overbought Stochastic Strength -3.33%
Pocket Pivot Bullish Swing Setup 0.00%

Older signals for SVRA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
Savara Inc., formerly Mast Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor. It is developing Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis, a rare lung disease. AIR001 is a sodium nitrite solution for inhalation via nebulization. AIR001 is in Phase II clinical development for the treatment of heart failure with preserved ejection fraction, also known as diastolic heart failure or heart failure with preserved systolic function.
Medicine Medical Specialties Pharmaceutical Cystic Fibrosis Heart Failure Staphylococcus Aureus Heart Diseases Treatment Of Heart Failure Total Synthesis
Is SVRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 Savara Inc. (SVRA) Q1 2019 Earnings Call Transcript
May 16 Savara Inc. (NASDAQ:SVRA) Is Expected To Breakeven
May 10 Savara Inc. (SVRA) CEO Rob Neville on Q1 2019 Results - Earnings Call Transcript
May 9 Savara beats by $0.03
May 9 Savara Reports First Quarter 2019 Financial Results and Provides Business Update
May 6 Savara's Molgradex Fast Track'd for rare autoimmune lung disorder
May 6 Savara Announces Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis
May 2 Savara to Report First Quarter 2019 Financial Results and Provide Business Update
Apr 23 TWTR, HAS, ASTE and RAD among notable midday movers
Apr 23 Savara: Simple Platform Targeting A Few Rare Diseases
See more SVRA news...
Indicators
Indicator Value
52 Week High 14.06
52 Week Low 6.21
Average Volume 249,138
200-Day Moving Average 9.1884
50-Day Moving Average 9.5196
20-Day Moving Average 10.994
10-Day Moving Average 11.218
Average True Range 0.5582
ADX 43.93
+DI 27.7078
-DI 12.172
Chandelier Exit (Long, 3 ATRs ) 10.2854
Chandelier Exit (Short, 3 ATRs ) 10.394600000000001
Upper Bollinger Band 11.6996
Lower Bollinger Band 10.2884
Percent B (%b) 0.72
BandWidth 12.836092
MACD Line 0.5524
MACD Signal Line 0.5942
MACD Histogram -0.0418
Fundamentals Value
Market Cap 273.74 Million
Num Shares 24.2 Million
EPS -3.50
Price-to-Earnings (P/E) Ratio -3.23
Price-to-Sales 526.42
Price-to-Book 2.64
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.00
Resistance 3 (R3) 11.99 11.75 11.89
Resistance 2 (R2) 11.75 11.57 11.76 11.85
Resistance 1 (R1) 11.53 11.47 11.41 11.54 11.81
Pivot Point 11.29 11.29 11.23 11.30 11.29
Support 1 (S1) 11.07 11.11 10.95 11.08 10.81
Support 2 (S2) 10.83 11.01 10.84 10.77
Support 3 (S3) 10.61 10.83 10.74
Support 4 (S4) 10.62